Abrogation of Triazole Resistance Upon Deletion of CDR1 in a Clinical Isolate of Candida Auris

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00057-19
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Candida Auris: The Path of Yeast Resistance

2020English

Draft Genome Sequence of Candida Auris Strain LOM, a Human Clinical Isolate From Greater Metropolitan Houston, Texas

Microbiology Resource Announcements
ImmunologyGeneticsMolecular BiologyMicrobiology
2019English

Norfloxacin Resistance in a Clinical Isolate of Escherichia Coli.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1987English

The ABCs of Candida Albicans Multidrug Transporter Cdr1

Eukaryotic Cell
2015English

nfxC-type Quinolone Resistance in a Clinical Isolate of Pseudomonas Aeruginosa

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1995English

Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida Parapsilosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Candida Auris: Problems in Diagnostics and Management

Voprosy Sovremennoi Pediatrii - Current Pediatrics
Child HealthPediatricsPerinatology
2020English

Berberine Inhibits Fluphenazine-Induced Up-Regulation of CDR1 in Candida Albicans

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2014English

Mediator Tail Module Is Required for Tac1 Activated CDR1 Expression and Azole Resistance in Candida Albicans .

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy